2m 2m 2m 2m 2m 2m 2m
ZENTALIS PHARMA (ZNTL)
NASDAQ
$2.48-$0.12 (-4.72%)
Price as of Oct 02, 2026 5:40 PM EDT- $246.6MMarket Cap
- 56.93%1-Year Change
- BiotechnologyIndustry
ZENTALIS PHARMA (ZNTL)
$2.48-$0.12 (-4.72%)
ZNTL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.60 | ||
Change | -$0.16 (-5.96%) | ||
Open | $2.74 | ||
High | $2.78 | ||
Low | $2.58 | ||
Previous Close | $2.77 | ||
Volume | 1,898,774 | ||
30-Day Average Volume | 1,231,774 | ||
1-Week Change | -5.27% | ||
1-Month Change | -29.78% | ||
1-Year Change | 56.93% | ||
3-Year Change | -87.01% | ||
5-Year Change | -96.12% | ||
Fundamentals | |||
Shares Outstanding | 94.7M | ||
Total Assets | $215.3M | ||
Market Cap | $246.6M | ||
Enterprise Value | $221.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$42.3M | ||
Free Cash Flow | -$37.2M | ||
EBIT | -$42.1M | ||
EBITDA | -$42.0M | ||
Net Working Capital | $143.7M | ||
EPS | -$0.59 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue